<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37332618</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1466-1861</ISSN><JournalIssue CitedMedium="Internet"><Volume>2023</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Mediators of inflammation</Title><ISOAbbreviation>Mediators Inflamm</ISOAbbreviation></Journal><ArticleTitle>Regulatory Mechanism of M1/M2 Macrophage Polarization in the Development of Autoimmune Diseases.</ArticleTitle><Pagination><StartPage>8821610</StartPage><MedlinePgn>8821610</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8821610</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2023/8821610</ELocationID><Abstract><AbstractText>Macrophages are innate immune cells in the organism and can be found in almost tissues and organs. They are highly plastic and heterogeneous cells and can participate in the immune response, thereby playing a crucial role in maintaining the immune homeostasis of the body. It is well known that undifferentiated macrophages can polarize into classically activated macrophages (M1 macrophages) and alternatively activated macrophages (M2 macrophages) under different microenvironmental conditions. The directions of macrophage polarization can be regulated by a series of factors, including interferon, lipopolysaccharide, interleukin, and noncoding RNAs. To elucidate the role of macrophages in various autoimmune diseases, we searched the literature on macrophages with the PubMed database. Search terms are as follows: macrophages, polarization, signaling pathways, noncoding RNA, inflammation, autoimmune diseases, systemic lupus erythematosus, rheumatoid arthritis, lupus nephritis, Sjogren's syndrome, Guillain-Barr&#xe9; syndrome, and multiple sclerosis. In the present study, we summarize the role of macrophage polarization in common autoimmune diseases. In addition, we also summarize the features and recent advances with a particular focus on the immunotherapeutic potential of macrophage polarization in autoimmune diseases and the potentially effective therapeutic targets.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Yuan Peng et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-4133-8329</Identifier><AffiliationInfo><Affiliation>Shandong University of Traditional Chinese Medicine, Jinan 250002, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Mengxian</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4343-869X</Identifier><AffiliationInfo><Affiliation>Shandong University of Traditional Chinese Medicine, Jinan 250002, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Hong</ForeName><Initials>H</Initials><Identifier Source="ORCID">0009-0001-8683-4633</Identifier><AffiliationInfo><Affiliation>Qingdao Traditional Chinese Medicine Hospital (Qingdao Hiser Hospital), Qingdao 266033, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qu</LastName><ForeName>Ruyi</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-1842-3063</Identifier><AffiliationInfo><Affiliation>Shandong University of Traditional Chinese Medicine, Jinan 250002, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-9145-6278</Identifier><AffiliationInfo><Affiliation>The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250002, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hao</LastName><ForeName>Jiawen</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-7242-9661</Identifier><AffiliationInfo><Affiliation>Shandong University of Traditional Chinese Medicine, Jinan 250002, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bi</LastName><ForeName>Hongsheng</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-6965-9626</Identifier><AffiliationInfo><Affiliation>Shandong Provincial Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Therapy of Ocular Diseases; Shandong Academy of Eye Disease Prevention and Therapy, Medical College of Optometry and Ophthalmology, Shandong University of Traditional Chinese Medicine, Jinan 250002, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Dadong</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-1712-0055</Identifier><AffiliationInfo><Affiliation>Shandong Provincial Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Therapy of Ocular Diseases; Shandong Academy of Eye Disease Prevention and Therapy, Medical College of Optometry and Ophthalmology, Shandong University of Traditional Chinese Medicine, Jinan 250002, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mediators Inflamm</MedlineTA><NlmUniqueID>9209001</NlmUniqueID><ISSNLinking>0962-9351</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008262" MajorTopicYN="N">Macrophage Activation</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>2</Hour><Minute>38</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37332618</ArticleId><ArticleId IdType="pmc">PMC10270764</ArticleId><ArticleId IdType="doi">10.1155/2023/8821610</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bieber K., Hundt J. E., Yu X., et al. Autoimmune pre-disease. Autoimmunity Reviews . 2023;22(2, article 103236) doi: 10.1016/j.autrev.2022.103236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2022.103236</ArticleId><ArticleId IdType="pubmed">36436750</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee for the Assessment of NIH Research on Autoimmune Diseases; Board on Population Health and Public Health Practice; Health and Medicine Division; National Academies of Sciences, Engineering, and Medicine. Enhancing NIH Research on Autoimmune Disease . Washington (DC): National Academies Press (US); 2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.17226/26554</ArticleId><ArticleId IdType="pubmed">35593778</ArticleId></ArticleIdList></Reference><Reference><Citation>Glover K., Mishra D., Singh T. R. R. Epidemiology of ocular manifestations in autoimmune disease. Frontiers in Immunology . 2021;12, article 744396 doi: 10.3389/fimmu.2021.744396.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.744396</ArticleId><ArticleId IdType="pmc">PMC8593335</ArticleId><ArticleId IdType="pubmed">34795665</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren P., Lu L., Cai S., Chen J., Lin W., Han F. Alternative splicing: a new cause and potential therapeutic target in autoimmune disease. Frontiers in Immunology . 2021;12, article 713540 doi: 10.3389/fimmu.2021.713540.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.713540</ArticleId><ArticleId IdType="pmc">PMC8416054</ArticleId><ArticleId IdType="pubmed">34484216</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolliniati O., Ieronymaki E., Vergadi E., Tsatsanis C. Metabolic regulation of macrophage activation. Journal of Innate Immunity . 2022;14(1):51&#x2013;68. doi: 10.1159/000516780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000516780</ArticleId><ArticleId IdType="pmc">PMC8787535</ArticleId><ArticleId IdType="pubmed">34247159</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynn T. A., Vannella K. M. Macrophages in tissue repair, regeneration, and fibrosis. Immunity . 2016;44(3):450&#x2013;462. doi: 10.1016/j.immuni.2016.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2016.02.015</ArticleId><ArticleId IdType="pmc">PMC4794754</ArticleId><ArticleId IdType="pubmed">26982353</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang N., Liang H., Zen K. Molecular mechanisms that influence the macrophage M1-M2 polarization balance. Frontiers in Immunology . 2014;5:p. 614. doi: 10.3389/fimmu.2014.00614.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00614</ArticleId><ArticleId IdType="pmc">PMC4246889</ArticleId><ArticleId IdType="pubmed">25506346</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Li J., Xie X., et al. Macrophage-osteoclast associations: origin, polarization, and subgroups. Frontiers in Immunology . 2021;12, article 778078 doi: 10.3389/fimmu.2021.778078.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.778078</ArticleId><ArticleId IdType="pmc">PMC8672114</ArticleId><ArticleId IdType="pubmed">34925351</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutilier A. J., Elsawa S. F. Macrophage polarization states in the tumor microenvironment. International Journal of Molecular Sciences . 2021;22(13):p. 6995. doi: 10.3390/ijms22136995.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22136995</ArticleId><ArticleId IdType="pmc">PMC8268869</ArticleId><ArticleId IdType="pubmed">34209703</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Heide D., Weiskirchen R., Bansal R. Therapeutic targeting of hepatic macrophages for the treatment of liver diseases. Frontiers in Immunology . 2019;10:p. 2852. doi: 10.3389/fimmu.2019.02852.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02852</ArticleId><ArticleId IdType="pmc">PMC6901832</ArticleId><ArticleId IdType="pubmed">31849997</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung E. J., Kwon S., Shankavaram U., White A. O., Das S., Citrin D. E. Natural variation in macrophage polarization and function impact pneumocyte senescence and susceptibility to fibrosis. Aging . 2022;14(19):7692&#x2013;7717. doi: 10.18632/aging.204309.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.204309</ArticleId><ArticleId IdType="pmc">PMC9596223</ArticleId><ArticleId IdType="pubmed">36173617</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson N. C., Rieder F., Wynn T. A. Fibrosis: from mechanisms to medicines. Nature . 2020;587(7835):555&#x2013;566. doi: 10.1038/s41586-020-2938-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2938-9</ArticleId><ArticleId IdType="pmc">PMC8034822</ArticleId><ArticleId IdType="pubmed">33239795</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawa M., Karim M. R., Izawa T., Kuwamura M., Yamate J. Immunophenotypical characterization of M1/M2 macrophages and lymphocytes in cisplatin-induced rat progressive renal fibrosis. Cells . 2021;10(2):p. 257. doi: 10.3390/cells10020257.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020257</ArticleId><ArticleId IdType="pmc">PMC7911194</ArticleId><ArticleId IdType="pubmed">33525592</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan J., Liu X., Wang H., Guo S. W. The M2a macrophage subset may be critically involved in the fibrogenesis of endometriosis in mice. Reproductive Biomedicine Online . 2018;37(3):254&#x2013;268. doi: 10.1016/j.rbmo.2018.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rbmo.2018.05.017</ArticleId><ArticleId IdType="pubmed">30314882</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutolo M., Campitiello R., Gotelli E., Soldano S. The role of M1/M2 macrophage polarization in rheumatoid arthritis synovitis. Frontiers in Immunology . 2022;13, article 867260 doi: 10.3389/fimmu.2022.867260.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.867260</ArticleId><ArticleId IdType="pmc">PMC9161083</ArticleId><ArticleId IdType="pubmed">35663975</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Han C. C., Cui D., Li Y., Ma Y., Wei W. Is macrophage polarization important in rheumatoid arthritis? International Immunopharmacology . 2017;50:345&#x2013;352. doi: 10.1016/j.intimp.2017.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2017.07.019</ArticleId><ArticleId IdType="pubmed">28750350</ArticleId></ArticleIdList></Reference><Reference><Citation>Tardito S., Martinelli G., Soldano S., et al. Macrophage M1/M2 polarization and rheumatoid arthritis: a systematic review. Autoimmunity Reviews . 2019;18(11, article 102397) doi: 10.1016/j.autrev.2019.102397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2019.102397</ArticleId><ArticleId IdType="pubmed">31520798</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Zhou Q., Xu W., et al. DNA-dependent activator of interferon-regulatory factors (DAI) promotes lupus nephritis by activating the calcium pathway. The Journal of Biological Chemistry . 2013;288(19):13534&#x2013;13550. doi: 10.1074/jbc.M113.457218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.457218</ArticleId><ArticleId IdType="pmc">PMC3650390</ArticleId><ArticleId IdType="pubmed">23553627</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishiguro N., Moriyama M., Furusho K., et al. Activated M2 macrophages contribute to the pathogenesis of IgG4-related disease via toll-like receptor 7/interleukin-33 signaling. Arthritis &amp; Rhematology . 2020;72(1):166&#x2013;178. doi: 10.1002/art.41052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41052</ArticleId><ArticleId IdType="pmc">PMC6972995</ArticleId><ArticleId IdType="pubmed">31339007</ArticleId></ArticleIdList></Reference><Reference><Citation>Yona S., Gordon S. From the reticuloendothelial to mononuclear phagocyte system - the unaccounted years. Frontiers in Immunology . 2015;6:p. 328. doi: 10.3389/fimmu.2015.00328.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2015.00328</ArticleId><ArticleId IdType="pmc">PMC4486871</ArticleId><ArticleId IdType="pubmed">26191061</ArticleId></ArticleIdList></Reference><Reference><Citation>Mertens C., Marques O., Horvat N. K., Simonetti M., Muckenthaler M. U., Jung M. The macrophage iron signature in health and disease. International Journal of Molecular Sciences . 2021;22(16):p. 8457. doi: 10.3390/ijms22168457.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22168457</ArticleId><ArticleId IdType="pmc">PMC8395084</ArticleId><ArticleId IdType="pubmed">34445160</ArticleId></ArticleIdList></Reference><Reference><Citation>Perdiguero E. G., Geissmann F. The development and maintenance of resident macrophages. Nature Immunology . 2016;17(1):2&#x2013;8. doi: 10.1038/ni.3341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3341</ArticleId><ArticleId IdType="pmc">PMC4950995</ArticleId><ArticleId IdType="pubmed">26681456</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Zhang L., Yu C., Yang X. F., Wang H. Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomarker Research . 2014;2(1):p. 1. doi: 10.1186/2050-7771-2-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2050-7771-2-1</ArticleId><ArticleId IdType="pmc">PMC3892095</ArticleId><ArticleId IdType="pubmed">24398220</ArticleId></ArticleIdList></Reference><Reference><Citation>Naito M., Umeda S., Yamamoto T., et al. Development, differentiation, and phenotypic heterogeneity of murine tissue macrophages. Journal of Leukocyte Biology . 1996;59(2):133&#x2013;138. doi: 10.1002/jlb.59.2.133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jlb.59.2.133</ArticleId><ArticleId IdType="pubmed">8603984</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies L. C., Jenkins S. J., Allen J. E., Taylor P. R. Tissue-resident macrophages. Nature Immunology . 2013;14(10):986&#x2013;995. doi: 10.1038/ni.2705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2705</ArticleId><ArticleId IdType="pmc">PMC4045180</ArticleId><ArticleId IdType="pubmed">24048120</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynn T. A., Chawla A., Pollard J. W. Macrophage biology in development, homeostasis and disease. Nature . 2013;496(7446):445&#x2013;455. doi: 10.1038/nature12034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12034</ArticleId><ArticleId IdType="pmc">PMC3725458</ArticleId><ArticleId IdType="pubmed">23619691</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruytinx P., Proost P., Van Damme J., Struyf S. Chemokine-induced macrophage polarization in inflammatory conditions. Frontiers in Immunology . 2018;9:p. 1930. doi: 10.3389/fimmu.2018.01930.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01930</ArticleId><ArticleId IdType="pmc">PMC6137099</ArticleId><ArticleId IdType="pubmed">30245686</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Zhang X. Pivotal regulators of tissue homeostasis and cancer: macrophages. Experimental Hematology &amp; Oncology . 2017;6:p. 23. doi: 10.1186/s40164-017-0083-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40164-017-0083-4</ArticleId><ArticleId IdType="pmc">PMC5549331</ArticleId><ArticleId IdType="pubmed">28804688</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesquida-Veny F., Del R&#xed;o J. A., Hervera A. Macrophagic and microglial complexity after neuronal injury. Progress in Neurobiology . 2021;200, article 101970 doi: 10.1016/j.pneurobio.2020.101970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2020.101970</ArticleId><ArticleId IdType="pubmed">33358752</ArticleId></ArticleIdList></Reference><Reference><Citation>Zabala A., Vazquez-Villoldo N., Rissiek B., et al. P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis. EMBO Molecular Medicine . 2018;10(8, article e8743) doi: 10.15252/emmm.201708743.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201708743</ArticleId><ArticleId IdType="pmc">PMC6079537</ArticleId><ArticleId IdType="pubmed">29973381</ArticleId></ArticleIdList></Reference><Reference><Citation>Thapa B., Lee K. Metabolic influence on macrophage polarization and pathogenesis. BMB Reports . 2019;52(6):360&#x2013;372. doi: 10.5483/BMBRep.2019.52.6.140.</Citation><ArticleIdList><ArticleId IdType="doi">10.5483/BMBRep.2019.52.6.140</ArticleId><ArticleId IdType="pmc">PMC6605523</ArticleId><ArticleId IdType="pubmed">31186085</ArticleId></ArticleIdList></Reference><Reference><Citation>Viola A., Munari F., S&#xe1;nchez-Rodr&#xed;guez R., Scolaro T., Castegna A. The metabolic signature of macrophage responses. Frontiers in Immunology . 2019;10:p. 1462. doi: 10.3389/fimmu.2019.01462.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01462</ArticleId><ArticleId IdType="pmc">PMC6618143</ArticleId><ArticleId IdType="pubmed">31333642</ArticleId></ArticleIdList></Reference><Reference><Citation>Kieler M., Hofmann M., Schabbauer G. More than just protein building blocks: how amino acids and related metabolic pathways fuel macrophage polarization. The FEBS Journal . 2021;288(12):3694&#x2013;3714. doi: 10.1111/febs.15715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15715</ArticleId><ArticleId IdType="pmc">PMC8359336</ArticleId><ArticleId IdType="pubmed">33460504</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Li N., Zhang X., Horng T. Mitochondrial metabolism regulates macrophage biology. The Journal of Biological Chemistry . 2021;297(1, article 100904) doi: 10.1016/j.jbc.2021.100904.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.100904</ArticleId><ArticleId IdType="pmc">PMC8294576</ArticleId><ArticleId IdType="pubmed">34157289</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcoran S. E., O'Neill L. A. J. HIF1&#x3b1; and metabolic reprogramming in inflammation. The Journal of Clinical Investigation . 2016;126(10):3699&#x2013;3707. doi: 10.1172/JCI84431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI84431</ArticleId><ArticleId IdType="pmc">PMC5096812</ArticleId><ArticleId IdType="pubmed">27571407</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X. H., Zhang D. W., Zheng X. L., Tang C. K. Itaconate: an emerging determinant of inflammation in activated macrophages. Immunology and Cell Biology . 2019;97(2):134&#x2013;141. doi: 10.1111/imcb.12218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imcb.12218</ArticleId><ArticleId IdType="pubmed">30428148</ArticleId></ArticleIdList></Reference><Reference><Citation>Peace C. G., O'Neill L. A. The role of itaconate in host defense and inflammation. The Journal of Clinical Investigation . 2022;132(2, article e148548) doi: 10.1172/JCI148548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI148548</ArticleId><ArticleId IdType="pmc">PMC8759771</ArticleId><ArticleId IdType="pubmed">35040439</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neill L. A., Artyomov M. N. Itaconate: the poster child of metabolic reprogramming in macrophage function. Nature Reviews Immunology . 2019;19(5):273&#x2013;281. doi: 10.1038/s41577-019-0128-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-019-0128-5</ArticleId><ArticleId IdType="pubmed">30705422</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosser D. M., Edwards J. P. Exploring the full spectrum of macrophage activation. Nature Reviews Immunology . 2008;8(12):958&#x2013;969. doi: 10.1038/nri2448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2448</ArticleId><ArticleId IdType="pmc">PMC2724991</ArticleId><ArticleId IdType="pubmed">19029990</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray P. J., Allen J. E., Biswas S. K., et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity . 2014;41(1):14&#x2013;20. doi: 10.1016/j.immuni.2014.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2014.06.008</ArticleId><ArticleId IdType="pmc">PMC4123412</ArticleId><ArticleId IdType="pubmed">25035950</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho H., Kwon H. Y., Lee S. H., Lee H. G., Kang N. Y., Chang Y. T. Development of a fluorescent probe for M2 macrophages via gating-oriented live-cell distinction. Journal of the American Chemical Society . 2023;145(5):2951&#x2013;2957. doi: 10.1021/jacs.2c11393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.2c11393</ArticleId><ArticleId IdType="pubmed">36705574</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamada M. M., Jia Y., Wu X. Macrophage polarization and plasticity in systemic lupus erythematosus. Frontiers in Immunology . 2021;12, article 734008 doi: 10.3389/fimmu.2021.734008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.734008</ArticleId><ArticleId IdType="pmc">PMC8721097</ArticleId><ArticleId IdType="pubmed">34987500</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray P. J., Wynn T. A. Obstacles and opportunities for understanding macrophage polarization. Journal of Leukocyte Biology . 2011;89(4):557&#x2013;563. doi: 10.1189/jlb.0710409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0710409</ArticleId><ArticleId IdType="pmc">PMC3058818</ArticleId><ArticleId IdType="pubmed">21248152</ArticleId></ArticleIdList></Reference><Reference><Citation>Locati M., Curtale G., Mantovani A. Diversity, mechanisms, and significance of macrophage plasticity. Annual Review of Pathology . 2020;15:123&#x2013;147. doi: 10.1146/annurev-pathmechdis-012418-012718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathmechdis-012418-012718</ArticleId><ArticleId IdType="pmc">PMC7176483</ArticleId><ArticleId IdType="pubmed">31530089</ArticleId></ArticleIdList></Reference><Reference><Citation>Avila-Ponce de Le&#xf3;n U., V&#xe1;zquez-Jim&#xe9;nez A., Matadamas-Guzman M., Pelayo R., Resendis-Antonio O. Transcriptional and microenvironmental landscape of macrophage transition in cancer: a Boolean analysis. Frontiers in Immunology . 2021;12, article 642842 doi: 10.3389/fimmu.2021.642842.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.642842</ArticleId><ArticleId IdType="pmc">PMC8222808</ArticleId><ArticleId IdType="pubmed">34177892</ArticleId></ArticleIdList></Reference><Reference><Citation>Funes S. C., Rios M., Escobar-Vera J., Kalergis A. M. Implications of macrophage polarization in autoimmunity. Immunology . 2018;154(2):186&#x2013;195. doi: 10.1111/imm.12910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12910</ArticleId><ArticleId IdType="pmc">PMC5980179</ArticleId><ArticleId IdType="pubmed">29455468</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross E. A., Devitt A., Johnson J. R. Macrophages: the good, the bad, and the gluttony. Frontiers in Immunology . 2021;12, article 708186 doi: 10.3389/fimmu.2021.708186.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.708186</ArticleId><ArticleId IdType="pmc">PMC8397413</ArticleId><ArticleId IdType="pubmed">34456917</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying W., Cheruku P. S., Bazer F. W., Safe S. H., Zhou B. Investigation of macrophage polarization using bone marrow derived macrophages. Journal of Visualized Experiments . 2013;76, article 50323 doi: 10.3791/50323.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/50323</ArticleId><ArticleId IdType="pmc">PMC3728835</ArticleId><ArticleId IdType="pubmed">23851980</ArticleId></ArticleIdList></Reference><Reference><Citation>Tariq M., Zhang J. Q., Liang G. K., He Q. J., Ding L., Yang B. Gefitinib inhibits M2-like polarization of tumor-associated macrophages in Lewis lung cancer by targeting the STAT6 signaling pathway. Acta Pharmacologica Sinica . 2017;38(11):1501&#x2013;1511. doi: 10.1038/aps.2017.124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2017.124</ArticleId><ArticleId IdType="pmc">PMC5672074</ArticleId><ArticleId IdType="pubmed">29022575</ArticleId></ArticleIdList></Reference><Reference><Citation>Harwani S. C. Macrophages under pressure: the role of macrophage polarization in hypertension. Translational Research . 2018;191:45&#x2013;63. doi: 10.1016/j.trsl.2017.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2017.10.011</ArticleId><ArticleId IdType="pmc">PMC5733698</ArticleId><ArticleId IdType="pubmed">29172035</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Ma C., Gong L., et al. Macrophage polarization and its role in liver disease. Frontiers in Immunology . 2021;12, article 803037 doi: 10.3389/fimmu.2021.803037.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.803037</ArticleId><ArticleId IdType="pmc">PMC8712501</ArticleId><ArticleId IdType="pubmed">34970275</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosser D. M., Hamidzadeh K., Goncalves R. Macrophages and the maintenance of homeostasis. Cellular &amp; Molecular Immunology . 2021;18(3):579&#x2013;587. doi: 10.1038/s41423-020-00541-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00541-3</ArticleId><ArticleId IdType="pmc">PMC7491045</ArticleId><ArticleId IdType="pubmed">32934339</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends in Immunology . 2004;25(12):677&#x2013;686. doi: 10.1016/j.it.2004.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2004.09.015</ArticleId><ArticleId IdType="pubmed">15530839</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L. X., Zhang S. X., Wu H. J., Rong X. L., Guo J. M2b macrophage polarization and its roles in diseases. Journal of Leukocyte Biology . 2019;106(2):345&#x2013;358. doi: 10.1002/JLB.3RU1018-378RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.3RU1018-378RR</ArticleId><ArticleId IdType="pmc">PMC7379745</ArticleId><ArticleId IdType="pubmed">30576000</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas J., Salazar J., Mart&#xed;nez M. S., et al. Macrophage heterogeneity and plasticity: impact of macrophage biomarkers on atherosclerosis. Scientifica . 2015;2015:17. doi: 10.1155/2015/851252.851252</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/851252</ArticleId><ArticleId IdType="pmc">PMC4600540</ArticleId><ArticleId IdType="pubmed">26491604</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelaziz M. H., Abdelwahab S. F., Wan J., et al. Alternatively activated macrophages; a double-edged sword in allergic asthma. Journal of Translational Medicine . 2020;18(1):p. 58. doi: 10.1186/s12967-020-02251-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02251-w</ArticleId><ArticleId IdType="pmc">PMC7003359</ArticleId><ArticleId IdType="pubmed">32024540</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R., Liao Y., Wang L., et al. Exosomes derived from M2b macrophages attenuate DSS-induced colitis. Frontiers in Immunology . 2019;10:p. 2346. doi: 10.3389/fimmu.2019.02346.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02346</ArticleId><ArticleId IdType="pmc">PMC6843072</ArticleId><ArticleId IdType="pubmed">31749791</ArticleId></ArticleIdList></Reference><Reference><Citation>Junior L. Y. S., Nguyen H. T., Salmanida F. P., Chang K. T. MERTK+/hi M2c macrophages induced by baicalin alleviate non-alcoholic fatty liver disease. International Journal of Molecular Sciences . 2021;22(19, article 10604) doi: 10.3390/ijms221910604.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221910604</ArticleId><ArticleId IdType="pmc">PMC8508959</ArticleId><ArticleId IdType="pubmed">34638941</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang P., Zhang X., Lin Z., et al. Adoptive transfer of polarized M2c macrophages ameliorates acute rejection in rat liver transplantation. American Journal of Translational Research . 2020;12(6):2614&#x2013;2626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7344085</ArticleId><ArticleId IdType="pubmed">32655794</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora S., Dev K., Agarwal B., Das P., Syed M. A. Macrophages: their role, activation and polarization in pulmonary diseases. Immunobiology . 2018;223(4-5):383&#x2013;396. doi: 10.1016/j.imbio.2017.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2017.11.001</ArticleId><ArticleId IdType="pmc">PMC7114886</ArticleId><ArticleId IdType="pubmed">29146235</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Ni H., Lan L., Wei X., Xiang R., Wang Y. Fra-1 protooncogene regulates IL-6 expression in macrophages and promotes the generation of M2d macrophages. Cell Research . 2010;20(6):701&#x2013;712. doi: 10.1038/cr.2010.52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2010.52</ArticleId><ArticleId IdType="pubmed">20386569</ArticleId></ArticleIdList></Reference><Reference><Citation>Orecchioni M., Ghosheh Y., Pramod A. B., Ley K. Macrophage polarization: different gene signatures in M1(LPS+) vs. classically and M2(LPS-) vs. Alternatively Activated Macrophages. Frontiers in Immunology . 2019;10:p. 1084. doi: 10.3389/fimmu.2019.01084.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01084</ArticleId><ArticleId IdType="pmc">PMC6543837</ArticleId><ArticleId IdType="pubmed">31178859</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xfc; W. D., Liu Y. Z., Yang Y. Q., et al. Effect of naturally derived surgical hemostatic materials on the proliferation of A549 human lung adenocarcinoma cells. Materials Today Bio . 2022;14, article 100233 doi: 10.1016/j.mtbio.2022.100233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mtbio.2022.100233</ArticleId><ArticleId IdType="pmc">PMC8913356</ArticleId><ArticleId IdType="pubmed">35280330</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y., Shi J., Guo Y., Shi G. Inhibition of angiogenetic macrophages reduces disc degeneration-associated pain. Frontiers in Bioengineering and Biotechnology . 2022;10, article 962155 doi: 10.3389/fbioe.2022.962155.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fbioe.2022.962155</ArticleId><ArticleId IdType="pmc">PMC9592909</ArticleId><ArticleId IdType="pubmed">36304897</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders C. B., Lawton T. M. W., Smith H. L., Garret J., Doucette M. M., Ammons M. C. B. Use of integrated metabolomics, transcriptomics, and signal protein profile to characterize the effector function and associated metabotype of polarized macrophage phenotypes. Journal of Leukocyte Biology . 2022;111(3):667&#x2013;693. doi: 10.1002/JLB.6A1120-744R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.6A1120-744R</ArticleId><ArticleId IdType="pmc">PMC8825884</ArticleId><ArticleId IdType="pubmed">34374126</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsui M., Corey D. R. Non-coding RNAs as drug targets. Nature Reviews Drug Discovery . 2017;16(3):167&#x2013;179. doi: 10.1038/nrd.2016.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd.2016.117</ArticleId><ArticleId IdType="pmc">PMC5831170</ArticleId><ArticleId IdType="pubmed">27444227</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Jiang T., Li M. Q., Zheng X. L., Zhao G. J. Transcriptional regulation of macrophages polarization by MicroRNAs. Frontiers in Immunology . 2018;9:p. 1175. doi: 10.3389/fimmu.2018.01175.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01175</ArticleId><ArticleId IdType="pmc">PMC5985397</ArticleId><ArticleId IdType="pubmed">29892301</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu X., Schulert G. S. Functional regulation of macrophage phenotypes by microRNAs in inflammatory arthritis. Frontiers in Immunology . 2019;10:p. 2217. doi: 10.3389/fimmu.2019.02217.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02217</ArticleId><ArticleId IdType="pmc">PMC6753331</ArticleId><ArticleId IdType="pubmed">31572403</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu W., Yu J., Qiu S., et al. MiR-let-7a regulates anti-citrullinated protein antibody-induced macrophage activation and correlates with the development of experimental rheumatoid arthritis. International Immunopharmacology . 2017;51:40&#x2013;46. doi: 10.1016/j.intimp.2017.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2017.08.001</ArticleId><ArticleId IdType="pubmed">28802150</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouimet M., Ediriweera H. N., Gundra U. M., et al. MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis. The Journal of Clinical Investigation . 2015;125(12):4334&#x2013;4348. doi: 10.1172/JCI81676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI81676</ArticleId><ArticleId IdType="pmc">PMC4665799</ArticleId><ArticleId IdType="pubmed">26517695</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen M. A., Hoang H. D., Rasheed A., et al. miR-223 exerts translational control of proatherogenic genes in macrophages. Circulation Research . 2022;131(1):42&#x2013;58. doi: 10.1161/CIRCRESAHA.121.319120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.319120</ArticleId><ArticleId IdType="pmc">PMC9213086</ArticleId><ArticleId IdType="pubmed">35611698</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng F., Henson R., Wehbe-Janek H., Ghoshal K., Jacob S. T., Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology . 2007;133(2):647&#x2013;658. doi: 10.1053/j.gastro.2007.05.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2007.05.022</ArticleId><ArticleId IdType="pmc">PMC4285346</ArticleId><ArticleId IdType="pubmed">17681183</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J. L., Huang F., He F., et al. Forced activation of notch in macrophages represses tumor growth by upregulating miR-125a and disabling tumor-associated macrophages. Cancer Research . 2016;76(6):1403&#x2013;1415. doi: 10.1158/0008-5472.CAN-15-2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-15-2019</ArticleId><ArticleId IdType="pubmed">26759236</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K., Yan G., Huang H., et al. Anti-inflammatory and immunomodulatory effects of the extracellular vesicles derived from human umbilical cord mesenchymal stem cells on osteoarthritis via M2 macrophages. Journal of Nanobiotechnology . 2022;20(1):p. 38. doi: 10.1186/s12951-021-01236-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12951-021-01236-1</ArticleId><ArticleId IdType="pmc">PMC8771624</ArticleId><ArticleId IdType="pubmed">35057811</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu Y., Guo R., Li J., et al. MiRNA regulation of MIF in SLE and attenuation of murine lupus nephritis with miR-654. Frontiers in Immunology . 2019;10:p. 2229. doi: 10.3389/fimmu.2019.02229.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02229</ArticleId><ArticleId IdType="pmc">PMC6761280</ArticleId><ArticleId IdType="pubmed">31608058</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Jia P., Ren T., et al. MicroRNA-382 promotes M2-like macrophage via the SIRP-&#x3b1;/STAT3 signaling pathway in aristolochic acid-induced renal fibrosis. Frontiers in Immunology . 2022;13, article 864984 doi: 10.3389/fimmu.2022.864984.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.864984</ArticleId><ArticleId IdType="pmc">PMC9108237</ArticleId><ArticleId IdType="pubmed">35585990</ArticleId></ArticleIdList></Reference><Reference><Citation>Quero L., Tiaden A. N., Hanser E., et al. miR-221-3p drives the shift of M2-macrophages to a pro-inflammatory function by suppressing JAK3/STAT3 activation. Frontiers in Immunology . 2020;10:p. 3087. doi: 10.3389/fimmu.2019.03087.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.03087</ArticleId><ArticleId IdType="pmc">PMC6996464</ArticleId><ArticleId IdType="pubmed">32047494</ArticleId></ArticleIdList></Reference><Reference><Citation>Giunti D., Marini C., Parodi B., et al. Role of miRNAs shuttled by mesenchymal stem cell-derived small extracellular vesicles in modulating neuroinflammation. Scientific Reports . 2021;11(1):p. 1740. doi: 10.1038/s41598-021-81039-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-81039-4</ArticleId><ArticleId IdType="pmc">PMC7814007</ArticleId><ArticleId IdType="pubmed">33462263</ArticleId></ArticleIdList></Reference><Reference><Citation>Negrini S., Emmi G., Greco M., et al. Sj&#xf6;gren's syndrome: a systemic autoimmune disease. Clinical and Experimental Medicine . 2022;22(1):9&#x2013;25. doi: 10.1007/s10238-021-00728-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-021-00728-6</ArticleId><ArticleId IdType="pmc">PMC8863725</ArticleId><ArticleId IdType="pubmed">34100160</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad I., Valverde A., Naqvi R. A., Naqvi A. R. Long non-coding RNAs RN7SK and GAS5 regulate macrophage polarization and innate immune responses. Frontiers in Immunology . 2020;11, article 604981 doi: 10.3389/fimmu.2020.604981.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.604981</ArticleId><ArticleId IdType="pmc">PMC7757381</ArticleId><ArticleId IdType="pubmed">33362791</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie C., Guo Y., Lou S. lncRNA ANCR promotes invasion and migration of gastric cancer by regulating FoxO1 expression to inhibit macrophage M1 polarization. Digestive Diseases and Sciences . 2020;65(10):2863&#x2013;2872. doi: 10.1007/s10620-019-06019-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-019-06019-1</ArticleId><ArticleId IdType="pubmed">31894487</ArticleId></ArticleIdList></Reference><Reference><Citation>Du M., Yuan L., Tan X., et al. The LPS-inducible lncRNA Mirt2 is a negative regulator of inflammation. Nature Communications . 2017;8(1):p. 2049. doi: 10.1038/s41467-017-02229-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02229-1</ArticleId><ArticleId IdType="pmc">PMC5725456</ArticleId><ArticleId IdType="pubmed">29230038</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayama Y., Fujiu K., Yuki R., et al. A long noncoding RNA regulates inflammation resolution by mouse macrophages through fatty acid oxidation activation. Proceedings of the National Academy of Sciences of the United States of America . 2020;117(25):14365&#x2013;14375. doi: 10.1073/pnas.2005924117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2005924117</ArticleId><ArticleId IdType="pmc">PMC7322040</ArticleId><ArticleId IdType="pubmed">32513690</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J., Li Z., Wu T., Zhao Q., Zhao Q., Cao Y. LncGBP9/miR-34a axis drives macrophages toward a phenotype conducive for spinal cord injury repair via STAT1/STAT6 and SOCS3. Journal of Neuroinflammation . 2020;17(1):p. 134. doi: 10.1186/s12974-020-01805-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01805-5</ArticleId><ArticleId IdType="pmc">PMC7187522</ArticleId><ArticleId IdType="pubmed">32345320</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun D., Yu Z., Fang X., et al. lncRNA GAS5 inhibits microglial M2 polarization and exacerbates demyelination. EMBO Reports . 2017;18(10):1801&#x2013;1816. doi: 10.15252/embr.201643668.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201643668</ArticleId><ArticleId IdType="pmc">PMC5623836</ArticleId><ArticleId IdType="pubmed">28808113</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X. X., Li Y. Y., Gong G., Geng H. Y. lncRNA260 siRNA accelerates M2 macrophage polarization and alleviates oxidative stress via inhibiting IL28RA gene alternative splicing. Oxidative Medicine and Cellular Longevity . 2022;2022:9. doi: 10.1155/2022/4942519.4942519</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/4942519</ArticleId><ArticleId IdType="pmc">PMC9525799</ArticleId><ArticleId IdType="pubmed">36193089</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Luo F., Jiang X., et al. CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype. Journal for Immunotherapy of Cancer . 2022;10(3, article e004029) doi: 10.1136/jitc-2021-004029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jitc-2021-004029</ArticleId><ArticleId IdType="pmc">PMC8919471</ArticleId><ArticleId IdType="pubmed">35277458</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X., Wang J., Guan J., et al. Exosomal Circsafb2 reshaping tumor environment to promote renal cell carcinoma progression by mediating M2 macrophage polarization. Frontiers in Oncology . 2022;12, article 808888 doi: 10.3389/fonc.2022.808888.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2022.808888</ArticleId><ArticleId IdType="pmc">PMC9133324</ArticleId><ArticleId IdType="pubmed">35646637</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu H., Chu L., Yuan Y. S., Liao S., Wang G. H. Circular RNA ACTR2 activates M2 polarization of macrophages through activating yes-associated protein signalling and contributes to renal fibrosis. Immunology . 2022;167(4):606&#x2013;621. doi: 10.1111/imm.13558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13558</ArticleId><ArticleId IdType="pubmed">36069177</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C. H., Lu Y. L., Huang H. T., et al. Association of lncRNA-GAS5 gene polymorphisms and PBMC LncRNA-GAS5 level with risk of systemic lupus erythematosus in Chinese population. Journal of Cellular and Molecular Medicine . 2021;25(7):3548&#x2013;3559. doi: 10.1111/jcmm.16438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.16438</ArticleId><ArticleId IdType="pmc">PMC8034459</ArticleId><ArticleId IdType="pubmed">33728802</ArticleId></ArticleIdList></Reference><Reference><Citation>Taheri M., Eghtedarian R., Dinger M. E., Ghafouri-Fard S. Exploring the role of non-coding RNAs in the pathophysiology of systemic lupus erythematosus. Biomolecules . 2020;10(6):p. 937. doi: 10.3390/biom10060937.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10060937</ArticleId><ArticleId IdType="pmc">PMC7356926</ArticleId><ArticleId IdType="pubmed">32580306</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Wu L., Qian J., et al. Identification of the long noncoding RNA NEAT1 as a novel inflammatory regulator acting through MAPK pathway in human lupus. Journal of Autoimmunity . 2016;75:96&#x2013;104. doi: 10.1016/j.jaut.2016.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2016.07.012</ArticleId><ArticleId IdType="pubmed">27481557</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao L., Jiang H., Yang J., et al. LncRNA MIR31HG is induced by tocilizumab and ameliorates rheumatoid arthritis fibroblast-like synoviocyte-mediated inflammation via miR-214-PTEN-AKT signaling pathway. Aging . 2021;13(21):24071&#x2013;24085. doi: 10.18632/aging.203644.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.203644</ArticleId><ArticleId IdType="pmc">PMC8610144</ArticleId><ArticleId IdType="pubmed">34753831</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu Y. R., Chang S. W., Lin Y. C., Yang C. H. Expression of microRNAs in the eyes of Lewis rats with experimental autoimmune anterior uveitis. Mediators of Inflammation . 2015;2015:11. doi: 10.1155/2015/457835.457835</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/457835</ArticleId><ArticleId IdType="pmc">PMC4680116</ArticleId><ArticleId IdType="pubmed">26713004</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Guo D., Liu B., et al. Regulatory role of rno-miR-30b-5p in IL-10 and toll-like receptor 4 expressions of T lymphocytes in experimental autoimmune uveitis in vitro. Mediators of Inflammation . 2018;2018:11. doi: 10.1155/2018/2574067.2574067</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/2574067</ArticleId><ArticleId IdType="pmc">PMC6231386</ArticleId><ArticleId IdType="pubmed">30510488</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhammad F., Trivett A., Wang D., Lee D. J. Tissue-specific production of microRNA-155 inhibits melanocortin 5 receptor-dependent suppressor macrophages to promote experimental autoimmune uveitis. European Journal of Immunology . 2019;49(11):2074&#x2013;2082. doi: 10.1002/eji.201848073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201848073</ArticleId><ArticleId IdType="pmc">PMC7306916</ArticleId><ArticleId IdType="pubmed">31177529</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Y., Luo X., Chen Y., et al. LncRNA and mRNA expression profile of peripheral blood mononuclear cells in primary Sj&#xf6;gren's syndrome patients. Scientific Reports . 2020;10(1):p. 19629. doi: 10.1038/s41598-020-76701-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-76701-2</ArticleId><ArticleId IdType="pmc">PMC7661519</ArticleId><ArticleId IdType="pubmed">33184486</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha S., Mona M., Lee K. E., Kim D. H., Han K. MicroRNAs in autoimmune Sj&#xf6;gren's syndrome. Genomics &amp; Informatics . 2018;16(4, article e19) doi: 10.5808/GI.2018.16.4.e19.</Citation><ArticleIdList><ArticleId IdType="doi">10.5808/GI.2018.16.4.e19</ArticleId><ArticleId IdType="pmc">PMC6440664</ArticleId><ArticleId IdType="pubmed">30602080</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N., Gao Z., Zhao L., et al. MSC-derived small extracellular vesicles attenuate autoimmune dacryoadenitis by promoting M2 macrophage polarization and inducing Tregs via miR-100-5p. Frontiers in Immunology . 2022;13, article 888949 doi: 10.3389/fimmu.2022.888949.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.888949</ArticleId><ArticleId IdType="pmc">PMC9298967</ArticleId><ArticleId IdType="pubmed">35874782</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D., Rose N. R. Women and autoimmune diseases. Emerging Infectious Diseases . 2004;10(11):p. 2005. doi: 10.3201/eid1011.040367.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1011.040367</ArticleId><ArticleId IdType="pmc">PMC3328995</ArticleId><ArticleId IdType="pubmed">15550215</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper G. S., Stroehla B. C. The epidemiology of autoimmune diseases. Autoimmunity Reviews . 2003;2(3):119&#x2013;125. doi: 10.1016/s1568-9972(03)00006-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1568-9972(03)00006-5</ArticleId><ArticleId IdType="pubmed">12848952</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo S. T., Steyn F. J., McCombe P. A. Gender differences in autoimmune disease. Frontiers in Neuroendocrinology . 2014;35(3):347&#x2013;369. doi: 10.1016/j.yfrne.2014.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yfrne.2014.04.004</ArticleId><ArticleId IdType="pubmed">24793874</ArticleId></ArticleIdList></Reference><Reference><Citation>Moorman C. D., Sohn S. J., Phee H. Emerging therapeutics for immune tolerance: tolerogenic vaccines, T cell therapy, and IL-2 therapy. Frontiers in Immunology . 2021;12, article 657768 doi: 10.3389/fimmu.2021.657768.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.657768</ArticleId><ArticleId IdType="pmc">PMC8039385</ArticleId><ArticleId IdType="pubmed">33854514</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulton V. R. Sex hormones in acquired immunity and autoimmune disease. Frontiers in Immunology . 2018;9:p. 2279. doi: 10.3389/fimmu.2018.02279.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02279</ArticleId><ArticleId IdType="pmc">PMC6180207</ArticleId><ArticleId IdType="pubmed">30337927</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard-Eaglin A., Smallheer B. A. Immunosuppressive/autoimmune disorders. The Nursing Clinics of North America . 2018;3:319&#x2013;334. doi: 10.1016/j.cnur.2018.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cnur.2018.04.002</ArticleId><ArticleId IdType="pubmed">30099999</ArticleId></ArticleIdList></Reference><Reference><Citation>Zucchi D., Elefante E., Calabresi E., Signorini V., Bortoluzzi A., Tani C. One year in review 2019: systemic lupus erythematosus. Clinical and Experimental Rheumatology . 2019;37(5):715&#x2013;722.</Citation><ArticleIdList><ArticleId IdType="pubmed">31376267</ArticleId></ArticleIdList></Reference><Reference><Citation>Narv&#xe1;ez J. Systemic lupus erythematosus 2020. Medicina Cl&#xed;nica . 2020;155(11):494&#x2013;501. doi: 10.1016/j.medcli.2020.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medcli.2020.05.009</ArticleId><ArticleId IdType="pubmed">32586673</ArticleId></ArticleIdList></Reference><Reference><Citation>Fava A., Petri M. Systemic lupus erythematosus: diagnosis and clinical management. Journal of Autoimmunity . 2019;96:1&#x2013;13. doi: 10.1016/j.jaut.2018.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2018.11.001</ArticleId><ArticleId IdType="pmc">PMC6310637</ArticleId><ArticleId IdType="pubmed">30448290</ArticleId></ArticleIdList></Reference><Reference><Citation>Illescas-Montes R., Corona-Castro C. C., Melguizo-Rodr&#xed;guez L., Ruiz C., Costela-Ruiz V. J. Infectious processes and systemic lupus erythematosus. Immunology . 2019;158(3):153&#x2013;160. doi: 10.1111/imm.13103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13103</ArticleId><ArticleId IdType="pmc">PMC6797874</ArticleId><ArticleId IdType="pubmed">31386190</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanouriakis A., Tziolos N., Bertsias G., Boumpas D. T. Update &#x3bf;n the diagnosis and management of systemic lupus erythematosus. Annals of the Rheumatic Diseases . 2021;80(1):14&#x2013;25. doi: 10.1136/annrheumdis-2020-218272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218272</ArticleId><ArticleId IdType="pubmed">33051219</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo G., Ye S., Xie S., et al. The cytomegalovirus protein US31 induces inflammation through mono-macrophages in systemic lupus erythematosus by promoting NF-&#x3ba;B2 activation. Cell Death &amp; Disease . 2018;9(2):p. 104. doi: 10.1038/s41419-017-0122-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-017-0122-4</ArticleId><ArticleId IdType="pmc">PMC5833803</ArticleId><ArticleId IdType="pubmed">29367719</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejon G., Valdivieso N., Flores-Santiba&#xf1;ez F., et al. Phenotypic and functional alterations of peritoneal macrophages in lupus-prone mice. Molecular Biology Reports . 2022;49(6):4193&#x2013;4204. doi: 10.1007/s11033-022-07252-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-022-07252-0</ArticleId><ArticleId IdType="pmc">PMC9262788</ArticleId><ArticleId IdType="pubmed">35211864</ArticleId></ArticleIdList></Reference><Reference><Citation>Labonte A. C., Kegerreis B., Geraci N. S., et al. Identification of alterations in macrophage activation associated with disease activity in systemic lupus erythematosus. PLoS One . 2018;13(12, article e0208132) doi: 10.1371/journal.pone.0208132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0208132</ArticleId><ArticleId IdType="pmc">PMC6298676</ArticleId><ArticleId IdType="pubmed">30562343</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouton A. J., Li X., Hall M. E., Hall J. E. Obesity, hypertension, and cardiac dysfunction: novel roles of immunometabolism in macrophage activation and inflammation. Circulation Research . 2020;126(6):789&#x2013;806. doi: 10.1161/CIRCRESAHA.119.312321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.119.312321</ArticleId><ArticleId IdType="pmc">PMC7255054</ArticleId><ArticleId IdType="pubmed">32163341</ArticleId></ArticleIdList></Reference><Reference><Citation>Maria N. I., Davidson A. Protecting the kidney in systemic lupus erythematosus: from diagnosis to therapy. Nature Reviews Rheumatology . 2020;16(5):255&#x2013;267. doi: 10.1038/s41584-020-0401-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-0401-9</ArticleId><ArticleId IdType="pubmed">32203285</ArticleId></ArticleIdList></Reference><Reference><Citation>Luan J., Fu J., Chen C., et al. LNA-anti-miR-150 ameliorated kidney injury of lupus nephritis by inhibiting renal fibrosis and macrophage infiltration. Arthritis Research &amp; Therapy . 2019;21(1):p. 276. doi: 10.1186/s13075-019-2044-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-019-2044-2</ArticleId><ArticleId IdType="pmc">PMC6907329</ArticleId><ArticleId IdType="pubmed">31829247</ArticleId></ArticleIdList></Reference><Reference><Citation>Orme J., Mohan C. Macrophage subpopulations in systemic lupus erythematosus. Discovery Medicine . 2012;13(69):151&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pubmed">22369974</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Xu W., Xiong S. Blockade of Notch1 signaling alleviates murine lupus via blunting macrophage activation and M2b polarization. Journal of Immunology . 2010;184(11):6465&#x2013;6478. doi: 10.4049/jimmunol.0904016.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0904016</ArticleId><ArticleId IdType="pubmed">20427764</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka Y., Luo Y., O'Shea J. J., Nakayamada S. Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach. Nature Reviews Rheumatology . 2022;18(3):133&#x2013;145. doi: 10.1038/s41584-021-00726-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-021-00726-8</ArticleId><ArticleId IdType="pmc">PMC8730299</ArticleId><ArticleId IdType="pubmed">34987201</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuykendall A. T., Komrokji R. S. JAK Be Nimble: reviewing the development of JAK inhibitors and JAK inhibitor combinations for special populations of patients with myelofibrosis. Journal of Immunotherapy and Precision Oncology . 2021;4(3):129&#x2013;141. doi: 10.36401/JIPO-20-36.</Citation><ArticleIdList><ArticleId IdType="doi">10.36401/JIPO-20-36</ArticleId><ArticleId IdType="pmc">PMC9138443</ArticleId><ArticleId IdType="pubmed">35663107</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang Q. M., Yang R., Zhang M., et al. Peripheral blood-derived mesenchymal stem cells modulate macrophage plasticity through the IL-10/STAT3 pathway. Stem Cells International . 2022;2022:19. doi: 10.1155/2022/5181241.5181241</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/5181241</ArticleId><ArticleId IdType="pmc">PMC9017453</ArticleId><ArticleId IdType="pubmed">35450344</ArticleId></ArticleIdList></Reference><Reference><Citation>Horuluoglu B., Bayik D., Kayraklioglu N., Goguet E., Kaplan M. J., Klinman D. M. PAM3 supports the generation of M2-like macrophages from lupus patient monocytes and improves disease outcome in murine lupus. Journal of Autoimmunity . 2019;99:24&#x2013;32. doi: 10.1016/j.jaut.2019.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.01.004</ArticleId><ArticleId IdType="pmc">PMC6462249</ArticleId><ArticleId IdType="pubmed">30679006</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayik D., Tross D., Haile L. A., Verthelyi D., Klinman D. M. Regulation of the maturation of human monocytes into immunosuppressive macrophages. Blood Advances . 2017;1(26):2510&#x2013;2519. doi: 10.1182/bloodadvances.2017011221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2017011221</ArticleId><ArticleId IdType="pmc">PMC5728638</ArticleId><ArticleId IdType="pubmed">29296902</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X., Xiao J., Jiang Q., et al. AKT2 reduces IFN&#x3b2;1 production to modulate antiviral responses and systemic lupus erythematosus. The EMBO Journal . 2022;41(6, article e108016) doi: 10.15252/embj.2021108016.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2021108016</ArticleId><ArticleId IdType="pmc">PMC8922272</ArticleId><ArticleId IdType="pubmed">35191555</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergtold A., Gavhane A., D'Agati V., Madaio M., Clynes R. FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis. Journal of Immunology . 2006;177(10):7287&#x2013;7295. doi: 10.4049/jimmunol.177.10.7287.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.177.10.7287</ArticleId><ArticleId IdType="pubmed">17082647</ArticleId></ArticleIdList></Reference><Reference><Citation>Mysore V., Tahir S., Furuhashi K., et al. Monocytes transition to macrophages within the inflamed vasculature via monocyte CCR2 and endothelial TNFR2. The Journal of Experimental Medicine . 2022;219(5, article e20210562) doi: 10.1084/jem.20210562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20210562</ArticleId><ArticleId IdType="pmc">PMC9006314</ArticleId><ArticleId IdType="pubmed">35404389</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders H. J., Ryu M. Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney International . 2011;80(9):915&#x2013;925. doi: 10.1038/ki.2011.217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2011.217</ArticleId><ArticleId IdType="pubmed">21814171</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J., Cao Q., Zheng D., et al. Discrete functions of M2a and M2c macrophage subsets determine their relative efficacy in treating chronic kidney disease. Kidney International . 2013;84(4):745&#x2013;755. doi: 10.1038/ki.2013.135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2013.135</ArticleId><ArticleId IdType="pubmed">23636175</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang C. L., Jiang H., Feng W., et al. Total Glucosides of paeony ameliorate pristane-induced lupus nephritis by inducing pd-1 ligands+ macrophages via activating IL-4/STAT6/PD-L2 signaling. Frontiers in Immunology . 2021;12, article 683249 doi: 10.3389/fimmu.2021.683249.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.683249</ArticleId><ArticleId IdType="pmc">PMC8288191</ArticleId><ArticleId IdType="pubmed">34290705</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalmers S. A., Glynn E., Garcia S. J., et al. BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis. Clinical Immunology . 2018;197:205&#x2013;218. doi: 10.1016/j.clim.2018.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2018.10.008</ArticleId><ArticleId IdType="pmc">PMC6384222</ArticleId><ArticleId IdType="pubmed">30339790</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringheim G. E., Wampole M., Oberoi K. Bruton's tyrosine kinase (BTK) inhibitors and autoimmune diseases: making sense of BTK inhibitor specificity profiles and recent clinical trial successes and failures. Frontiers in Immunology . 2021;12, article 662223 doi: 10.3389/fimmu.2021.662223.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.662223</ArticleId><ArticleId IdType="pmc">PMC8595937</ArticleId><ArticleId IdType="pubmed">34803999</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Xu W., Zhou R. NLRP3 inflammasome activation and cell death. Cellular &amp; Molecular Immunology . 2021;18(9):2114&#x2013;2127. doi: 10.1038/s41423-021-00740-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00740-6</ArticleId><ArticleId IdType="pmc">PMC8429580</ArticleId><ArticleId IdType="pubmed">34321623</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisitpongpun P., Potup P., Usuwanthim K. Oleamide-mediated polarization of M1 macrophages and IL-1&#x3b2; production by regulating NLRP3-inflammasome activation in primary human monocyte-derived macrophages. Frontiers in Immunology . 2022;13, article 856296 doi: 10.3389/fimmu.2022.856296.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.856296</ArticleId><ArticleId IdType="pmc">PMC9062104</ArticleId><ArticleId IdType="pubmed">35514993</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Liu L., Li L. Lentivirus-mediated knockdown of Fc&#x3b3;RI (CD64) attenuated lupus nephritis via inhibition of NF-&#x3ba;B regulating NLRP3 inflammasome activation in MRL/lpr mice. Journal of Pharmacological Sciences . 2018;137(4):342&#x2013;349. doi: 10.1016/j.jphs.2018.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphs.2018.05.012</ArticleId><ArticleId IdType="pubmed">30190171</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishimoto D., Kirino Y., Tamura M., et al. Dysregulated heme oxygenase-1low M2-like macrophages augment lupus nephritis via Bach1 induced by type I interferons. Arthritis Research &amp; Therapy . 2018;20(1):p. 64. doi: 10.1186/s13075-018-1568-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-018-1568-1</ArticleId><ArticleId IdType="pmc">PMC5894134</ArticleId><ArticleId IdType="pubmed">29636091</ArticleId></ArticleIdList></Reference><Reference><Citation>Almutairi K., Nossent J., Preen D., Keen H., Inderjeeth C. The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatology International . 2021;41(5):863&#x2013;877. doi: 10.1007/s00296-020-04731-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-020-04731-0</ArticleId><ArticleId IdType="pubmed">33175207</ArticleId></ArticleIdList></Reference><Reference><Citation>Almutairi K. B., Nossent J. C., Preen D. B., Keen H. I., Inderjeeth C. A. The prevalence of rheumatoid arthritis: a systematic review of population-based studies. The Journal of Rheumatology . 2021;48(5):669&#x2013;676. doi: 10.3899/jrheum.200367.</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.200367</ArticleId><ArticleId IdType="pubmed">33060323</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y. J., Anzaghe M., Sch&#xfc;lke S. Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells . 2020;9(4):p. 880. doi: 10.3390/cells9040880.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9040880</ArticleId><ArticleId IdType="pmc">PMC7226834</ArticleId><ArticleId IdType="pubmed">32260219</ArticleId></ArticleIdList></Reference><Reference><Citation>Sparks J. A. Rheumatoid arthritis. Annals of Internal Medicine . 2019;170(1):ITC1&#x2013;ITC16. doi: 10.7326/AITC201901010.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/AITC201901010</ArticleId><ArticleId IdType="pubmed">30596879</ArticleId></ArticleIdList></Reference><Reference><Citation>Atzeni F., Talotta R., Masala I. F., Bongiovanni S., Boccassini L., Sarzi-Puttini P. Biomarkers in rheumatoid arthritis. The Israel Medical Association Journal . 2017;19(8):512&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pubmed">28825772</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;&#xe7;&#xfc;kdeveci A. A. Nonpharmacological treatment in established rheumatoid arthritis. Best Practice &amp; Research. Clinical Rheumatology . 2019;33(5, article 101482) doi: 10.1016/j.berh.2019.101482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.berh.2019.101482</ArticleId><ArticleId IdType="pubmed">31987686</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Hu Z., Cai S., Shen G., Zhong J., Dong L. Efficacy of plasma exchange on top of standard immunosuppressive therapy in adult autoimmune inflammatory rheumatic diseases-associated macrophage activation syndrome, a single center real-world analysis. Seminars in Arthritis and Rheumatism . 2022;55, article 152043 doi: 10.1016/j.semarthrit.2022.152043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2022.152043</ArticleId><ArticleId IdType="pubmed">35696776</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Guo L., Wang Z., et al. Targeted silver nanoparticles for rheumatoid arthritis therapy via macrophage apoptosis and Re-polarization. Biomaterials . 2021;264, article 120390 doi: 10.1016/j.biomaterials.2020.120390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2020.120390</ArticleId><ArticleId IdType="pubmed">32980634</ArticleId></ArticleIdList></Reference><Reference><Citation>Demarco B., Danielli S., Fischer F. A., Bezbradica J. S. How pyroptosis contributes to inflammation and fibroblast-macrophage cross-talk in rheumatoid arthritis. Cells . 2022;11(8):p. 1307. doi: 10.3390/cells11081307.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11081307</ArticleId><ArticleId IdType="pmc">PMC9028325</ArticleId><ArticleId IdType="pubmed">35455985</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutet M. A., Courties G., Nerviani A., et al. Novel insights into macrophage diversity in rheumatoid arthritis synovium. Autoimmunity Reviews . 2021;20(3, article 102758) doi: 10.1016/j.autrev.2021.102758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102758</ArticleId><ArticleId IdType="pubmed">33476818</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemble S., Croft A. P. Critical role of synovial tissue-resident macrophage and fibroblast subsets in the persistence of joint inflammation. Frontiers in Immunology . 2021;12, article 715894 doi: 10.3389/fimmu.2021.715894.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.715894</ArticleId><ArticleId IdType="pmc">PMC8446662</ArticleId><ArticleId IdType="pubmed">34539648</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemke G. Phosphatidylserine is the signal for TAM receptors and their ligands. Trends in Biochemical Sciences . 2017;42(9):738&#x2013;748. doi: 10.1016/j.tibs.2017.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2017.06.004</ArticleId><ArticleId IdType="pmc">PMC5600686</ArticleId><ArticleId IdType="pubmed">28734578</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H., Back J. H., Han G., et al. Extracellular vesicle-guided in situ reprogramming of synovial macrophages for the treatment of rheumatoid arthritis. Biomaterials . 2022;286, article 121578 doi: 10.1016/j.biomaterials.2022.121578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2022.121578</ArticleId><ArticleId IdType="pubmed">35594838</ArticleId></ArticleIdList></Reference><Reference><Citation>Han C., Yang Y., Sheng Y., et al. Glaucocalyxin B inhibits cartilage inflammatory injury in rheumatoid arthritis by regulating M1 polarization of synovial macrophages through NF-&#x3ba;B pathway. Aging . 2021;13(18):22544&#x2013;22555. doi: 10.18632/aging.203567.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.203567</ArticleId><ArticleId IdType="pmc">PMC8507279</ArticleId><ArticleId IdType="pubmed">34580236</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y., Liu J., Huang C., et al. Wilforlide A ameliorates the progression of rheumatoid arthritis by inhibiting M1 macrophage polarization. Journal of Pharmacological Sciences . 2022;148(1):116&#x2013;124. doi: 10.1016/j.jphs.2021.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphs.2021.10.005</ArticleId><ArticleId IdType="pubmed">34924115</ArticleId></ArticleIdList></Reference><Reference><Citation>Degbo&#xe9; Y., Rauwel B., Baron M., et al. Polarization of rheumatoid macrophages by TNF targeting through an IL-10/STAT3 mechanism. Frontiers in Immunology . 2019;10:p. 3. doi: 10.3389/fimmu.2019.00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00003</ArticleId><ArticleId IdType="pmc">PMC6345709</ArticleId><ArticleId IdType="pubmed">30713533</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Y. M., Zhang L. L., Lu W. T., Shang Y. N., Zhou H. Y. Moxibustion regulates the polarization of macrophages through the IL-4/STAT6 pathway in rheumatoid arthritis. Cytokine . 2022;152, article 155835 doi: 10.1016/j.cyto.2022.155835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2022.155835</ArticleId><ArticleId IdType="pubmed">35240467</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo S. J., Noh H. S., Lee N. Y., et al. Myeloid sirtuin 6 deficiency accelerates experimental rheumatoid arthritis by enhancing macrophage activation and infiltration into synovium. eBioMedicine . 2018;38:228&#x2013;237. doi: 10.1016/j.ebiom.2018.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.11.005</ArticleId><ArticleId IdType="pmc">PMC6306347</ArticleId><ArticleId IdType="pubmed">30429089</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y., Ka S. O., Cha H. N., et al. Myeloid sirtuin 6 deficiency causes insulin resistance in high-fat diet-fed mice by eliciting macrophage polarization toward an M1 phenotype. Diabetes . 2017;66(10):2659&#x2013;2668. doi: 10.2337/db16-1446.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db16-1446</ArticleId><ArticleId IdType="pubmed">28607107</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Feng Y., Zheng X., et al. M2-type exosomes nanoparticles for rheumatoid arthritis therapy via macrophage re-polarization. Journal of Controlled Release . 2022;341:16&#x2013;30. doi: 10.1016/j.jconrel.2021.11.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2021.11.019</ArticleId><ArticleId IdType="pubmed">34793917</ArticleId></ArticleIdList></Reference><Reference><Citation>Feige J., Moser T., Bieler L., Schwenker K., Hauer L., Sellner J. Vitamin D supplementation in multiple sclerosis: a critical analysis of potentials and threats. Nutrients . 2020;12(3):p. 783. doi: 10.3390/nu12030783.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12030783</ArticleId><ArticleId IdType="pmc">PMC7146466</ArticleId><ArticleId IdType="pubmed">32188044</ArticleId></ArticleIdList></Reference><Reference><Citation>Houen G., Trier N. H., Frederiksen J. L. Epstein-Barr virus and multiple sclerosis. Frontiers in Immunology . 2020;11, article 587078 doi: 10.3389/fimmu.2020.587078.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.587078</ArticleId><ArticleId IdType="pmc">PMC7773893</ArticleId><ArticleId IdType="pubmed">33391262</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfredsson L., Olsson T. Lifestyle and environmental factors in multiple sclerosis. Cold Spring Harbor Perspectives in Medicine . 2019;9(4, article a028944) doi: 10.1101/cshperspect.a028944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a028944</ArticleId><ArticleId IdType="pmc">PMC6444694</ArticleId><ArticleId IdType="pubmed">29735578</ArticleId></ArticleIdList></Reference><Reference><Citation>Tafti D., Ehsan M., Xixis K. L. StatPearls . Treasure Island (FL): StatPearls Publishing; 2022. Multiple Sclerosis. 2022 Apr 9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29763024</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauser S. L., Cree B. A. C. Treatment of multiple sclerosis: a review. The American Journal of Medicine . 2020;133(12):1380&#x2013;1390.e2. doi: 10.1016/j.amjmed.2020.05.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2020.05.049</ArticleId><ArticleId IdType="pmc">PMC7704606</ArticleId><ArticleId IdType="pubmed">32682869</ArticleId></ArticleIdList></Reference><Reference><Citation>Kami&#x144;ska J., Koper O. M., Piechal K., Kemona H. Multiple sclerosis - etiology and diagnostic potential. Post&#x229;py Higieny i Medycyny Do&#x15b;wiadczalnej . 2017;71:551&#x2013;563. doi: 10.5604/01.3001.0010.3836.</Citation><ArticleIdList><ArticleId IdType="doi">10.5604/01.3001.0010.3836</ArticleId><ArticleId IdType="pubmed">28665284</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel D. Y., Vereyken E. J., Glim J. E., et al. Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. Journal of Neuroinflammation . 2013;10:p. 35. doi: 10.1186/1742-2094-10-35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-10-35</ArticleId><ArticleId IdType="pmc">PMC3610294</ArticleId><ArticleId IdType="pubmed">23452918</ArticleId></ArticleIdList></Reference><Reference><Citation>Leuti A., Talamonti E., Gentile A., et al. Macrophage plasticity and polarization are altered in the experimental model of multiple sclerosis. Biomolecules . 2021;11(6):p. 837. doi: 10.3390/biom11060837.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11060837</ArticleId><ArticleId IdType="pmc">PMC8229971</ArticleId><ArticleId IdType="pubmed">34200023</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang F., Liu X., Cui X., et al. Circ_0000518 promotes macrophage/microglia M1 polarization via the FUS/CaMKK&#x3b2;/AMPK pathway to aggravate multiple sclerosis. Neuroscience . 2022;490:131&#x2013;143. doi: 10.1016/j.neuroscience.2021.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2021.12.012</ArticleId><ArticleId IdType="pubmed">34920022</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamma E., Lasisi W., Libner C., Ng H. S., Plemel J. R. Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics. Journal of Neuroinflammation . 2022;19(1):p. 45. doi: 10.1186/s12974-022-02408-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-022-02408-y</ArticleId><ArticleId IdType="pmc">PMC8830034</ArticleId><ArticleId IdType="pubmed">35144628</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuntzel T., Bagnard D. Manipulating macrophage/microglia polarization to treat glioblastoma or multiple sclerosis. Pharmaceutics . 2022;14(2):p. 344. doi: 10.3390/pharmaceutics14020344.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics14020344</ArticleId><ArticleId IdType="pmc">PMC8877500</ArticleId><ArticleId IdType="pubmed">35214076</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B., Tan T. B., Wang L., Zhao X. Y., Tan G. J. p38MAPK/SGK1 signaling regulates macrophage polarization in experimental autoimmune encephalomyelitis. Aging . 2019;11(3):898&#x2013;907. doi: 10.18632/aging.101786.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101786</ArticleId><ArticleId IdType="pmc">PMC6382436</ArticleId><ArticleId IdType="pubmed">30716717</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi M., Mi L., Li F., et al. Fluvoxamine confers neuroprotection via inhibiting infiltration of peripheral leukocytes and M1 polarization of microglia/macrophages in a mouse model of traumatic brain injury. Journal of Neurotrauma . 2022;39(17-18):1240&#x2013;1261. doi: 10.1089/neu.2021.0355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2021.0355</ArticleId><ArticleId IdType="pubmed">35502478</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Hu Y., Wang B., et al. Dopamine uses the DRD5-ARRB2-PP2A signaling axis to block the TRAF6-mediated NF-&#x3ba;B pathway and suppress systemic inflammation. Molecular Cell . 2020;78(1):42&#x2013;56.e6. doi: 10.1016/j.molcel.2020.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.01.022</ArticleId><ArticleId IdType="pubmed">32035036</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshioka Y., Sugino Y., Shibagaki F., Yamamuro A., Ishimaru Y., Maeda S. Dopamine attenuates lipopolysaccharide-induced expression of proinflammatory cytokines by inhibiting the nuclear translocation of NF-&#x3ba;B p65 through the formation of dopamine quinone in microglia. European Journal of Pharmacology . 2020;866, article 172826 doi: 10.1016/j.ejphar.2019.172826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2019.172826</ArticleId><ArticleId IdType="pubmed">31790652</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Zhang X., Niu X., et al. Mdivi-1 modulates macrophage/microglial polarization in mice with EAE via the inhibition of the TLR2/4-GSK3&#x3b2;-NF-&#x3ba;B inflammatory signaling axis. Molecular Neurobiology . 2022;59(1):1&#x2013;16. doi: 10.1007/s12035-021-02552-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02552-1</ArticleId><ArticleId IdType="pubmed">34618332</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., Dong C., Ubogu E. E. Immunotherapy of Guillain-Barr&#xe9; syndrome. Human Vaccines &amp; Immunotherapeutics . 2018;14(11):2568&#x2013;2579. doi: 10.1080/21645515.2018.1493415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2018.1493415</ArticleId><ArticleId IdType="pmc">PMC6314401</ArticleId><ArticleId IdType="pubmed">29953326</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonhard S. E., Mandarakas M. R., Gondim F. A. A., et al. Diagnosis and management of Guillain-Barr&#xe9; syndrome in ten steps. Nature Reviews Neurology . 2019;15(11):671&#x2013;683. doi: 10.1038/s41582-019-0250-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0250-9</ArticleId><ArticleId IdType="pmc">PMC6821638</ArticleId><ArticleId IdType="pubmed">31541214</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspi R. R., Silver P. B., Luger D., et al. Mouse models of experimental autoimmune uveitis. Ophthalmic Research . 2008;40(3-4):169&#x2013;174. doi: 10.1159/000119871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000119871</ArticleId><ArticleId IdType="pmc">PMC2735820</ArticleId><ArticleId IdType="pubmed">18421234</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyati K. K., Prasad K. N., Rizwan A., Verma A., Paliwal V. K. TH1 and TH2 response to Campylobacter jejuni antigen in Guillain-Barre syndrome. Archives of Neurology . 2011;68(4):445&#x2013;452. doi: 10.1001/archneurol.2011.51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.51</ArticleId><ArticleId IdType="pubmed">21482924</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen D., Chu F., Lang Y., et al. Beneficial or harmful role of macrophages in Guillain-Barr&#xe9; syndrome and experimental autoimmune neuritis. Mediators of Inflammation . 2018;2018:10. doi: 10.1155/2018/4286364.4286364</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/4286364</ArticleId><ArticleId IdType="pmc">PMC5944239</ArticleId><ArticleId IdType="pubmed">29853789</ArticleId></ArticleIdList></Reference><Reference><Citation>Du T., Yang C. L., Ge M. R., et al. M1 macrophage derived exosomes aggravate experimental autoimmune neuritis via modulating Th1 response. Frontiers in Immunology . 2020;11:p. 1603. doi: 10.3389/fimmu.2020.01603.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01603</ArticleId><ArticleId IdType="pmc">PMC7390899</ArticleId><ArticleId IdType="pubmed">32793234</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J., Chi F., Tsukamoto H. Notch signaling and M1 macrophage activation in obesity-alcohol synergism. Clinics and Research in Hepatology and Gastroenterology . 2015;39(1):S24&#x2013;S28. doi: 10.1016/j.clinre.2015.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinre.2015.05.016</ArticleId><ArticleId IdType="pmc">PMC4656026</ArticleId><ArticleId IdType="pubmed">26189984</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L., Li L., Zhang C. Y., Schluesener H., Zhang Z. Y. Natural diterpenoid oridonin ameliorates experimental autoimmune neuritis by promoting anti-inflammatory macrophages through blocking Notch pathway. Frontiers in Neuroscience . 2019;13:p. 272. doi: 10.3389/fnins.2019.00272.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00272</ArticleId><ArticleId IdType="pmc">PMC6454011</ArticleId><ArticleId IdType="pubmed">31001070</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen D., Chu F., Lang Y., et al. Nuclear factor kappa B inhibitor suppresses experimental autoimmune neuritis in mice via declining macrophages polarization to M1 type. Clinical and Experimental Immunology . 2021;206(1):110&#x2013;117. doi: 10.1111/cei.13637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13637</ArticleId><ArticleId IdType="pmc">PMC8446411</ArticleId><ArticleId IdType="pubmed">34118070</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu X., Chen Y., Chen D. The role of gut microbiome in autoimmune uveitis. Ophthalmic Research . 2021;64(2):168&#x2013;177. doi: 10.1159/000510212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000510212</ArticleId><ArticleId IdType="pubmed">32674100</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Zhu L., Wang R., et al. Therapeutic effect of IL-38 on experimental autoimmune uveitis: reprogrammed immune cell landscape and reduced Th17 cell pathogenicity. Investigative Ophthalmology &amp; Visual Science . 2021;62(15):p. 31. doi: 10.1167/iovs.62.15.31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.62.15.31</ArticleId><ArticleId IdType="pmc">PMC8727319</ArticleId><ArticleId IdType="pubmed">34967854</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;rida S., Palacios E., Navea A., Bosch-Morell F. Macrophages and uveitis in experimental animal models. Mediators of Inflammation . 2015;2015:10. doi: 10.1155/2015/671417.671417</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/671417</ArticleId><ArticleId IdType="pmc">PMC4452861</ArticleId><ArticleId IdType="pubmed">26078494</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Zhou W., Su G., Hu J., Yang P. Progranulin suppressed autoimmune uveitis and autoimmune neuroinflammation by inhibiting Th1/Th17 cells and promoting Treg cells and M2 macrophages. Neurology - Neuroimmunology Neuroinflammation . 2022;9(2, article e1133) doi: 10.1212/NXI.0000000000001133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001133</ArticleId><ArticleId IdType="pmc">PMC8791655</ArticleId><ArticleId IdType="pubmed">35082168</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X., Wei H., Wu S., et al. DAPT reverses the Th17/Treg imbalance in experimental autoimmune uveitis in vitro via inhibiting Notch signaling pathway. International Immunopharmacology . 2020;79, article 106107 doi: 10.1016/j.intimp.2019.106107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2019.106107</ArticleId><ArticleId IdType="pubmed">31863921</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X., Qiu Y., Li Z., et al. Longdan Xiegan decoction alleviates experimental autoimmune uveitis in rats by inhibiting Notch signaling pathway activation and Th17 cell differentiation. Biomedicine &amp; Pharmacotherapy . 2021;136, article 111291 doi: 10.1016/j.biopha.2021.111291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.111291</ArticleId><ArticleId IdType="pubmed">33493870</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X., Guo L., Zhou M., Qiu Y., Bi H., Guo D. Regulatory role of Longdan Xiegan decoction in polarization balance of M1/M2 macrophages in rats with experimental autoimmune uveitis. Recent Advances in Ophthalmology . 2021;41(5):408&#x2013;412. doi: 10.13389/j.cnki.rao.2021.0085.</Citation><ArticleIdList><ArticleId IdType="doi">10.13389/j.cnki.rao.2021.0085</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S. C. Non-canonical NF-&#x3ba;B signaling pathway. Cell Research . 2011;21(1):71&#x2013;85. doi: 10.1038/cr.2010.177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2010.177</ArticleId><ArticleId IdType="pmc">PMC3193406</ArticleId><ArticleId IdType="pubmed">21173796</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Zhao C., Meng J., et al. Galectin-3 regulates microglial activation and promotes inflammation through TLR4/MyD88/NF-kB in experimental autoimmune uveitis. Clinical Immunology . 2022;236, article 108939 doi: 10.1016/j.clim.2022.108939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2022.108939</ArticleId><ArticleId IdType="pubmed">35121106</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Kitaichi N., Wu D., et al. Attenuation of experimental autoimmune uveoretinitis in mice by IKK&#x3b2; inhibitor IMD-0354. Biochemical and Biophysical Research Communications . 2020;525(3):589&#x2013;594. doi: 10.1016/j.bbrc.2020.02.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.02.117</ArticleId><ArticleId IdType="pubmed">32115150</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Li Z., Li H., et al. Apremilast regulates the Teff/Treg balance to ameliorate uveitis via PI3K/AKT/FoxO1 signaling pathway. Frontiers in Immunology . 2020;11, article 581673 doi: 10.3389/fimmu.2020.581673.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.581673</ArticleId><ArticleId IdType="pmc">PMC7705241</ArticleId><ArticleId IdType="pubmed">33281814</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G., Li X., Li N., et al. Icariin alleviates uveitis by targeting peroxiredoxin 3 to modulate retinal microglia M1/M2 phenotypic polarization. Redox Biology . 2022;52, article 102297 doi: 10.1016/j.redox.2022.102297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2022.102297</ArticleId><ArticleId IdType="pmc">PMC8956882</ArticleId><ArticleId IdType="pubmed">35334248</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavragani C. P., Moutsopoulos H. M. Sj&#xf6;gren syndrome. CMAJ . 2014;186(15):E579&#x2013;E586. doi: 10.1503/cmaj.122037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.122037</ArticleId><ArticleId IdType="pmc">PMC4203623</ArticleId><ArticleId IdType="pubmed">24566651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogawa Y., Shimizu E., Tsubota K. Interferons and dry eye in Sj&#xf6;gren's syndrome. International Journal of Molecular Sciences . 2018;19(11):p. 3548. doi: 10.3390/ijms19113548.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19113548</ArticleId><ArticleId IdType="pmc">PMC6274689</ArticleId><ArticleId IdType="pubmed">30423813</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe5;ve U., Nordmark G., L&#xf6;vgren T., et al. Activation of the type I interferon system in primary Sj&#xf6;gren's syndrome: a possible etiopathogenic mechanism. Arthritis and Rheumatism . 2005;52(4):1185&#x2013;1195. doi: 10.1002/art.20998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.20998</ArticleId><ArticleId IdType="pubmed">15818675</ArticleId></ArticleIdList></Reference><Reference><Citation>Emamian E. S., Leon J. M., Lessard C. J., et al. Peripheral blood gene expression profiling in Sj&#xf6;gren's syndrome. Genes and Immunity . 2009;10(4):285&#x2013;296. doi: 10.1038/gene.2009.20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gene.2009.20</ArticleId><ArticleId IdType="pmc">PMC3273959</ArticleId><ArticleId IdType="pubmed">19404300</ArticleId></ArticleIdList></Reference><Reference><Citation>Chivasso C., Sarrand J., Perret J., Delporte C., Soyfoo M. S. The involvement of innate and adaptive immunity in the initiation and perpetuation of Sj&#xf6;gren's syndrome. International Journal of Molecular Sciences . 2021;22(2):p. 658. doi: 10.3390/ijms22020658.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22020658</ArticleId><ArticleId IdType="pmc">PMC7826728</ArticleId><ArticleId IdType="pubmed">33440862</ArticleId></ArticleIdList></Reference><Reference><Citation>Baturone R., Soto M. J., M&#xe1;rquez M., et al. Health-related quality of life in patients with primary Sj&#xf6;gren's syndrome: relationship with serum levels of proinflammatory cytokines. Scandinavian Journal of Rheumatology . 2009;38(5):386&#x2013;389. doi: 10.1080/03009740902973821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03009740902973821</ArticleId><ArticleId IdType="pubmed">19575332</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu X., Li N., Zhao L., et al. Human umbilical cord mesenchymal stem cells alleviate ongoing autoimmune dacryoadenitis in rabbits via polarizing macrophages into an anti-inflammatory phenotype. Experimental Eye Research . 2020;191, article 107905 doi: 10.1016/j.exer.2019.107905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exer.2019.107905</ArticleId><ArticleId IdType="pmc">PMC8612174</ArticleId><ArticleId IdType="pubmed">31891674</ArticleId></ArticleIdList></Reference><Reference><Citation>Raes G., Brys L., Dahal B. K., et al. Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation. Journal of Leukocyte Biology . 2005;77(3):321&#x2013;327. doi: 10.1189/jlb.0304212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0304212</ArticleId><ArticleId IdType="pubmed">15591125</ArticleId></ArticleIdList></Reference><Reference><Citation>Frangogiannis N. Transforming growth factor-&#x3b2; in tissue fibrosis. The Journal of Experimental Medicine . 2020;217(3, article e20190103) doi: 10.1084/jem.20190103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20190103</ArticleId><ArticleId IdType="pmc">PMC7062524</ArticleId><ArticleId IdType="pubmed">32997468</ArticleId></ArticleIdList></Reference><Reference><Citation>Hata A., Chen Y. G. TGF-&#x3b2; signaling from receptors to Smads. Cold Spring Harbor Perspectives in Biology . 2016;8(9, article a022061) doi: 10.1101/cshperspect.a022061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a022061</ArticleId><ArticleId IdType="pmc">PMC5008074</ArticleId><ArticleId IdType="pubmed">27449815</ArticleId></ArticleIdList></Reference><Reference><Citation>Su J., Morgani S. M., David C. J., et al. TGF-&#x3b2; orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1. Nature . 2020;577(7791):566&#x2013;571. doi: 10.1038/s41586-019-1897-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1897-5</ArticleId><ArticleId IdType="pmc">PMC7450666</ArticleId><ArticleId IdType="pubmed">31915377</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Kim Y. S., Park S. H. Metformin as a treatment strategy for Sj&#xf6;gren's syndrome. International Journal of Molecular Sciences . 2021;22(13):p. 7231. doi: 10.3390/ijms22137231.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22137231</ArticleId><ArticleId IdType="pmc">PMC8269365</ArticleId><ArticleId IdType="pubmed">34281285</ArticleId></ArticleIdList></Reference><Reference><Citation>Long D., Chen Y., Wu H., Zhao M., Lu Q. Clinical significance and immunobiology of IL-21 in autoimmunity. Journal of Autoimmunity . 2019;99:1&#x2013;14. doi: 10.1016/j.jaut.2019.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.01.013</ArticleId><ArticleId IdType="pubmed">30773373</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Y., Cui G., Gao Y. Research progress on inflammatory mechanism of primary Sj&#xf6;gren syndrome. Zhejiang Da Xue Xue Bao. Yi Xue Ban . 2021;50(6):783&#x2013;794. doi: 10.3724/zdxbyxb-2021-0072.</Citation><ArticleIdList><ArticleId IdType="doi">10.3724/zdxbyxb-2021-0072</ArticleId><ArticleId IdType="pmc">PMC8931614</ArticleId><ArticleId IdType="pubmed">35347914</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiripolsky J., Romano R. A., Kasperek E. M., Yu G., Kramer J. M. Activation of Myd88-dependent TLRs mediates local and systemic inflammation in a mouse model of primary Sj&#xf6;gren's syndrome. Frontiers in Immunology . 2020;10:p. 2963. doi: 10.3389/fimmu.2019.02963.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02963</ArticleId><ArticleId IdType="pmc">PMC6964703</ArticleId><ArticleId IdType="pubmed">31993047</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutolo M., Soldano S., Smith V. Pathophysiology of systemic sclerosis: current understanding and new insights. Expert Review of Clinical Immunology . 2019;15(7):753&#x2013;764. doi: 10.1080/1744666X.2019.1614915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2019.1614915</ArticleId><ArticleId IdType="pubmed">31046487</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown M., O'Reilly S. The immunopathogenesis of fibrosis in systemic sclerosis. Clinical and Experimental Immunology . 2019;195(3):310&#x2013;321. doi: 10.1111/cei.13238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13238</ArticleId><ArticleId IdType="pmc">PMC6378383</ArticleId><ArticleId IdType="pubmed">30430560</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C., Tang J., Liu S., et al. Cathepsin B/NLRP3/GSDMD axis-mediated macrophage pyroptosis induces inflammation and fibrosis in systemic sclerosis. Journal of Dermatological Science . 2022;108(3):127&#x2013;137. doi: 10.1016/j.jdermsci.2022.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdermsci.2022.12.006</ArticleId><ArticleId IdType="pubmed">36585288</ArticleId></ArticleIdList></Reference><Reference><Citation>Lescoat A., Lelong M., Jeljeli M., et al. Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: perspectives for scleroderma-associated interstitial lung disease. Biochemical Pharmacology . 2020;178, article 114103 doi: 10.1016/j.bcp.2020.114103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2020.114103</ArticleId><ArticleId IdType="pubmed">32562787</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudnik M., Hukara A., Kocherova I., et al. Elevated fibronectin levels in profibrotic CD14+ monocytes and CD14+ macrophages in systemic sclerosis. Frontiers in Immunology . 2021;12, article 642891 doi: 10.3389/fimmu.2021.642891.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.642891</ArticleId><ArticleId IdType="pmc">PMC8421541</ArticleId><ArticleId IdType="pubmed">34504485</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang M., Smith A., Watson M., et al. Self-assembled human skin equivalents model macrophage activation of cutaneous fibrogenesis in systemic sclerosis. Arthritis &amp; Rhematology . 2022;74(7):1245&#x2013;1256. doi: 10.1002/art.42097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.42097</ArticleId><ArticleId IdType="pmc">PMC9340654</ArticleId><ArticleId IdType="pubmed">35212485</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun C., Cai D., Chen S. Y. ADAR1 promotes systemic sclerosis via modulating classic macrophage activation. Frontiers in Immunology . 2022;13, article 1051254 doi: 10.3389/fimmu.2022.1051254.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1051254</ArticleId><ArticleId IdType="pmc">PMC9751044</ArticleId><ArticleId IdType="pubmed">36532023</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Zhang L., Wu G. R., et al. MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program. Science Advances . 2021;7(1) doi: 10.1126/sciadv.abb6075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abb6075</ArticleId><ArticleId IdType="pmc">PMC7775789</ArticleId><ArticleId IdType="pubmed">33277324</ArticleId></ArticleIdList></Reference><Reference><Citation>Abron J. D., Singh N. P., Price R. L., Nagarkatti M., Nagarkatti P. S., Singh U. P. Genistein induces macrophage polarization and systemic cytokine to ameliorate experimental colitis. PLoS One . 2018;13(7, article e0199631) doi: 10.1371/journal.pone.0199631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0199631</ArticleId><ArticleId IdType="pmc">PMC6053137</ArticleId><ArticleId IdType="pubmed">30024891</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Huang B., Jiang X., et al. Mucosal-associated invariant T cells improve nonalcoholic fatty liver disease through regulating macrophage polarization. Frontiers in Immunology . 2018;9:p. 1994. doi: 10.3389/fimmu.2018.01994.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01994</ArticleId><ArticleId IdType="pmc">PMC6131560</ArticleId><ArticleId IdType="pubmed">30233587</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen V. T., Farman N., Palacios-Ramirez R., et al. Cutaneous wound healing in diabetic mice is improved by topical mineralocorticoid receptor blockade. The Journal of Investigative Dermatology . 2020;140(1):223&#x2013;234.e7. doi: 10.1016/j.jid.2019.04.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jid.2019.04.030</ArticleId><ArticleId IdType="pubmed">31278904</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>